对KDM4基因组脱甲基酶抑制剂的专利审查 (2014年至今)
Xiaolong Yang1,2, Yuyan Han1,2, Lei Yu3
1Department of Medicinal Chemistry, Shanghai Institute of Materia Medica, Chinese Academy of Sciences Shanghai, China.
Expert opinion on therapeutic patents
|January 8, 2026
概括
KDM4抑制剂在癌症治疗方面表现有前途,但面临着诸如细胞透率差等挑战. 新的策略和对KDM4功能的进一步研究对于开发有效的治疗方法至关重要.
科学领域:
- 在瘤学瘤学.
- 生物化学 生物化学
- 药用化学 医学化学
背景情况:
- 基因组脱甲基酶的KDM4家族 (KDM4A-F) 与各种癌症有关.
- 异常的KDM4表达在瘤学中呈现治疗点.
- 在临床试验中,TACH101是KDM4抑制剂的一个例子.
研究的目的:
- 对KDM4抑制剂的专利文献进行审查.
- 从2014年6月到2025年5月,分析了17项专利申请.
主要方法:
- 使用Cortellis药物发现情报系统的文献搜索.
- 对已确认的专利申请进行批判性分析.
主要成果:
- 在KDM4抑制剂开发方面取得显著进展.
- 目前的抑制剂面临着挑战:膜透性差,细胞功效有限,同位素特异性低.
结论:
- 新型支架,共价抑制剂,蛋白质降解剂和向非催化域是潜在的解决方案.
- 对KDM4生物作用的进一步研究对于合理的药物设计和临床转化至关重要.
相关概念视频
Spreading of Chromatin Modifications
9.3K
The histone proteins in the nucleosomes are post-translationally modified (PTM) to increase or decrease access to DNA. The commonly observed PTMs are methylation, acetylation, phosphorylation, and ubiquitination of lysine amino acids in the histone H3 tail region. These histone modifications have specific meaning for the cell. Hence, they are called "histone code". The protein complex involved in histone modification is termed as "reader-writer" complex.
Writers
The writer...
Writers
The writer...
9.3K
Histone Variants at the Centromere
4.9K
Histone variants are the histone proteins with structural and sequence variations. These variants may be regarded as “mutant” forms that replace their canonical histone counterparts in the nucleosomes. Specific post-translational modifications on the histone variants enable further chromatin complexity and regulate tissue-specific gene expression. The most common histone variants are from histone H2A, H2B, and linker histone H1 families. However, several variants of histone H3...
4.9K
Histone Modification
15.9K
The histone proteins have a flexible N-terminal tail extending out from the nucleosome. These histone tails are often subjected to post-translational modifications such as acetylation, methylation, phosphorylation, and ubiquitination. Particular combinations of these modifications form “histone codes” that influence the chromatin folding and tissue-specific gene expression.
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
Acetylation
The enzyme histone acetyltransferase adds acetyl group to the histones. Another enzyme, histone...
15.9K
Histone Modification
4.4K
4.4K
Chromatin Modification in iPS Cells
2.1K
Chromatin modification alters gene expression; therefore, scientists can add histone-modifying enzymes, histone variants, and chromatin remodeling complexes to somatic cells to aid reprogramming into pluripotent stem (iPS) cells.
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
Compact chromatin makes reprogramming difficult. Enzymes, such as histone demethylases and acetyltransferases, are often added during reprogramming to loosen the chromatin, making the DNA more accessible to transcription factors. Molecules that inhibit histone...
2.1K
Chromatin Immunoprecipitation- ChIP
12.1K
Chromatin immunoprecipitation, or ChIP, is an antibody-based technique used to identify sites on DNA that bind to transcription factors of interest or histone proteins. It also helps determine the type of histone modifications such as acetylation, phosphorylation, or methylation.
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
Types of ChIP
ChIP can be divided into two types - X-ChIP and N-ChIP. X-ChIP involves in vivo cross-linking of histones and regulatory proteins to DNA, fragmenting the DNA by sonication, and isolating the protein-DNA...
12.1K


